Brain Computer Interface (BCI) is an early stage neuroscience diagnostics and biomarker technology company focused on delivering actionable data regarding brain functionality to patients, physicians, and life sciences companies to assess both normal and compromised brain health. BCl’s proprietary technology will leverage recent advances in wireless dry electrode electro-encephalography (EEG) hardware to create diagnostic and screening tools. BCl’s products and services will be used to monitor brain health in a variety of settings, focusing first on the diseased or injured brain including the diagnosis of Alzheimer’s disease (AD) and mild Traumatic Brain Injury (mTBI). Through extensive testing, BCI aims to also assess healthy normal brains. To date there is no objective, rigorously validated, clinically qualified and affordable diagnostic tool to assess normal healthy brain functionality. BCI will fill this gap by combining advances in current hardware with innovative and thorough brain testing regimens.

University Partner: Villanova University